Rock Oak Core Growth holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Rock Oak Core Growth Fund RCKSX
- NAV / 1-Day Return $25.39 / −0.16 %
- Fund Size $14.1M
- Adjusted Expense Ratio 1.250%
- Net Expense Ratio 1.250%
- Fee Level: Distribution High
- Share Class Type Institutional
- Morningstar Category Mid-Cap Blend
- Equity Style Box (Funds) Mid Blend
- Minimum Initial Investment $2,000
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 12%
Morningstar’s Analysis RCKSX
Will RCKSX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 37.0
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Prime 3.53 10/1/26 | 9.06 | 1M | — |
Exelixis Inc | 4.42 | 693,560 | Healthcare |
Applied Industrial Technologies Inc | 4.10 | 643,313 | Industrials |
F5 Inc | 4.10 | 643,285 | Technology |
Cardinal Health Inc | 3.85 | 603,198 | Healthcare |
Nordson Corp | 3.85 | 602,916 | Industrials |
APA Corp | 3.58 | 561,704 | Energy |
NetApp Inc | 3.49 | 546,628 | Technology |
Quest Diagnostics Inc | 3.22 | 504,597 | Healthcare |
Jazz Pharmaceuticals PLC | 3.20 | 502,167 | Healthcare |